Myasthenia gravis

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Myasthenia gravis is a disorder of neuromuscular transmission that results in skeletal muscle weakness. The affected individual produces antibodies that are directed against their own nicotinic acetylcholine receptors. The circulating antibodies interfere with binding of acetylcholine to the ....

Original languageEnglish
Title of host publicationxPharm: The Comprehensive Pharmacology Reference
PublisherElsevier Inc.
Pages1-5
Number of pages5
ISBN (Print)9780080552323
DOIs
StatePublished - 2011

Fingerprint

Myasthenia Gravis
Neuromuscular Junction Diseases
Antibodies
Muscle Weakness
Nicotinic Receptors
Acetylcholine
Skeletal Muscle

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Kincaid, A. (2011). Myasthenia gravis. In xPharm: The Comprehensive Pharmacology Reference (pp. 1-5). Elsevier Inc.. https://doi.org/10.1016/B978-008055232-3.60686-5

Myasthenia gravis. / Kincaid, Anthony.

xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., 2011. p. 1-5.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kincaid, A 2011, Myasthenia gravis. in xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., pp. 1-5. https://doi.org/10.1016/B978-008055232-3.60686-5
Kincaid A. Myasthenia gravis. In xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc. 2011. p. 1-5 https://doi.org/10.1016/B978-008055232-3.60686-5
Kincaid, Anthony. / Myasthenia gravis. xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., 2011. pp. 1-5
@inbook{7bb1a71978474f11b388b71994fb87f6,
title = "Myasthenia gravis",
abstract = "Myasthenia gravis is a disorder of neuromuscular transmission that results in skeletal muscle weakness. The affected individual produces antibodies that are directed against their own nicotinic acetylcholine receptors. The circulating antibodies interfere with binding of acetylcholine to the ....",
author = "Anthony Kincaid",
year = "2011",
doi = "10.1016/B978-008055232-3.60686-5",
language = "English",
isbn = "9780080552323",
pages = "1--5",
booktitle = "xPharm: The Comprehensive Pharmacology Reference",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - CHAP

T1 - Myasthenia gravis

AU - Kincaid, Anthony

PY - 2011

Y1 - 2011

N2 - Myasthenia gravis is a disorder of neuromuscular transmission that results in skeletal muscle weakness. The affected individual produces antibodies that are directed against their own nicotinic acetylcholine receptors. The circulating antibodies interfere with binding of acetylcholine to the ....

AB - Myasthenia gravis is a disorder of neuromuscular transmission that results in skeletal muscle weakness. The affected individual produces antibodies that are directed against their own nicotinic acetylcholine receptors. The circulating antibodies interfere with binding of acetylcholine to the ....

UR - http://www.scopus.com/inward/record.url?scp=84884059540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884059540&partnerID=8YFLogxK

U2 - 10.1016/B978-008055232-3.60686-5

DO - 10.1016/B978-008055232-3.60686-5

M3 - Chapter

AN - SCOPUS:84884059540

SN - 9780080552323

SP - 1

EP - 5

BT - xPharm: The Comprehensive Pharmacology Reference

PB - Elsevier Inc.

ER -